Gut Microbiota Dysbiosis and PAGln-Mediated Immune Dysregulation in Coronary Heart Disease Subtypes
This study enrolled 100 controls and 302 coronary heart disease (CHD) patients, including 102 with acute coronary syndrome (ACS), 100 with chronic stable angina pectoris (CSAP), and 100 with ischemic cardiomyopathy (ICM). Gut microbiota was analyzed via 16S rRNA gene sequencing.